IXHL:NASDAQIncannex Healthcare Inc. analysis
Data as of Sep 15, 2026 - not real-time
- Latest price
- $3.29
- Risk: high
- 9/10High risk
Summary
The moving-average structure behind Incannex Healthcare Inc. is neutral at $3.29, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 11.9%. Relative strength is 47.8 — neutral — and the MACD signal is bearish. The recent range runs from support at $3.13 up to resistance at $3.94.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 451.8% above the current quote.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 44.5%, a beta of 1.45 and a maximum drawdown of 87.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 451.8% above the current quote.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 44.5%, a beta of 1.45 and a maximum drawdown of 87.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top market events
- NEW YORK and MELBOURNE, Australia, Aug. 25, 2026 GLOBE NEWSWIRE -- Incannex Healthcare Inc. Nasdaq: IXHL "Incannex" or...
- Incannex Receives Additional A$5.1 Million R&D Tax Incentive Refund, Completing More Than A$11.2 Million In...
- Detailed price information for Incannex Healthcare Inc ADR IXHL-Q from The Globe and Mail including charting and trades.
Market outlook
Short term
< 1 yearNeutral
Model confidence2/102 out of 10
Key factors
- Trading below the 200-day average of 5.72
- MACD momentum is negative
- 30-day price change of +11.9%
Medium term
1–3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Trading below the 200-day average of 5.72
- Analyst targets imply +451.8% versus the current price
- 30-day volatility of 44.5%
Long term
> 3 yearsNeutral
Model confidence1/101 out of 10
Key factors
- Analyst targets imply +451.8% versus the current price
- Negative return on equity of -117.2%
- Negative free cash flow
Key metrics
Financial health
P/E Ratio-1.9
ROE-117.17%
ROA-32.19%
Debt/Equity0.15
P/B Ratio0.6
Op. Cash Flow$-17723000
Free Cash Flow$-8271875
Industry P/E30.0
Technical analysis
TrendNeutral
RSI47.8
Support$3.13
Resistance$3.94
MA 20$3.42
MA 50$3.28
MA 200$5.72
MACDBearish
VolumeDecreasing
Fear & Greed Index90.18
Valuation
Target Price$18.15
Upside/Downside451.76%
GradeUndervalued
TypeBlend
Risk assessment
Beta1.45
Volatility44.47%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.